Next Generation Sequencing Market Demand, Supply, Growth Factors, Latest Rising Trend & Forecast to 2025


According to The Insight Partners market research study titled Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts by Product, Services, Applications, and End-Users, the global next generation sequencing market was valued at US$ 5,731.3 Mn in 2017 and is estimated to reach US$ 26,501.2 Mn by 2025. The report highlights the trends prevalent in the global next generation sequencing market and the factors driving the market along with those that act as deterrents to its growth.

The global next generation sequencing market is a matured market in the developing countries as well as developing economies worldwide. The necessity of genetic analysis is constantly increasing in recent days due to the reliable and accurate results being offered by the technique. The demand for next generation sequencing is experienced mostly from academic institutions followed by hospitals & clinics. Among the applications, the demand for next generation sequencing is significantly high in diagnostics, drug discovery, followed by precision medicine. Furthermore, advancements in sequencing technologies and declining cost of sequencing is expected to be a driving factor for the next generation market.

Get PDF Sample Copy of this Report @ https://bit.ly/2K6yTAW



Top Dominating Key Players:

1. Illumina, Inc.
2. Thermo Fisher Scientific, Inc.
3. Qiagen N.V.
4. Beijing Genomics Institute
5. Perkinelmer, Inc.
6. F. Hoffmann-La Roche AG
7. Agilent Technologies
8. Eurofins Scientific
9. Oxford Nanopore Technologies, Ltd.
10. Macrogen, Inc.

Modification and automation of this process continued to increase sequencing data and time reduction. Thereby allowing researchers to reach major milestones in the Human Genome Project. NGS makes sequence based gene expression analysis a "digital? alternative to analog techniques. It also aids in quantifying RNA expression with the breadth of a microarray and the resolution of qPCR. Advancement in genome sequencing has made the sequencing easy and accurate. These technological advancement are likely to grow the market in near future.

Cancer can be cured if diagnosed and treated at an initial stage. Cancer sequencing using next-generation sequencing (NGS) methods provides more information. Additionally, NGS also aids in diagnostics and treatment of cancer. In recent years, the cases of cancer has been increasing tremendously and the trend is anticipated to remain the same in the upcoming years. Due to preference of better technologies for detection of fatal disease, the demand for next generation sequencing is anticipated to witness constant growth in the upcoming years.

The market for next generation sequencing is well established in the region of North America, owing to the awareness regarding medical practices and technological developments in the process of next generation technology. Various market players have been focusing towards shifting their customer base in North America. For instance, Illumina, Inc. along with Telegraph, established a company called Verogen. The company would be entitled to provide Illumina's forensic products to the customers in the US.

Reasons to Buy the Report :

·         Learn about the driving factors, affecting the market growth.
·         Imbibe the advancements and progress in the market during the forecast period.
·         Understand where the market opportunities lies.
·         Compare and evaluate various options affecting the market.
·         Pick up on the leading market players within the market.
·         Envision the restrictions and restrains that are likely to hamper the market.

Comments

Post a Comment

Popular posts from this blog

Immunochemistry Equipment Market to Reflect a Holistic Expansion During 2019 to 2027

Image
The growth of the market is driven by the factors such as, rising incidences of chronic and infectious diseases and increasing geriatric population. However, the market is likely to slower down its growth due to the limitations associated with immunohistochemistry. The countries in the region are creating significant opportunities for the key market players to expand their business. It is likely to be a major factor contributing to the market growth during the coming years. With rising costs of production against their practices, the healthcare companies are striving to produce sufficient revenue to entertain their investors. The markets in some growing economies are expected to be an essential part of offering more reliable and profitable growth opportunities for the major players to expand their industry and geographic scope. Register for a free Trial today and gain instant*access @ Click Here Key Players Influencing the Market: PerkinElmer, Inc. Abcam Plc Ag...
Read more

Biopharmaceutical Contract Manufacturing Market to Witness an Outstanding Growth by 2027

Image
The growth of the market is driven by factors such as the increasing outsourcing by pharmaceutical companies and increasing demand of biologics in the European region. However, increasing competition in the industry is likely to restrain the market growth to a certain extent. Manufacturing of Biopharmaceutical medicines through contract manufacturer from DNA to finished final product. Contract manufacturing is the type of outsourcing where a company enters into an agreement or legal settlement with another manufacturing firm for products, parts, or components, which the former will then use in its production process to complete its product. Register for a free Trial today and gain instant*access @ Click Here Key Players Influencing the Market: Lonza Group AG Boehringer Ingelheim International GmbH Inno Biologics Ventures Sdn Bhd Thermo Fisher Scientific AbbVie Inc. WuXi Biologics General Electric Samsung Biologics Merck KGaA Ajinomoto Co., Inc ...
Read more

Patient Registry Software Market Set for Rapid Growth and Trend by 2027

Image
The factors contributing to the growth of the Patient Registry Software market in Growing expenditure of digital healthcare, rising number of patients enrolling in patient registries and others. In the past few years, the Patient Registry has become a significant field in the North America medical sector, experiencing good development vision for the treatment of some challenging diseases. The government of the country organized various awareness programs for utilization of the patient registry. Moreover, the growing number of players operating across the region for patient registry software. The countries such as US and Canada are estimated to serve various growth opportunities due to the rising development in the healthcare IT sector. Register for a free Trial today and gain instant*access @ Click Here Key Players Influencing the Market: ARMUS Corporation CEDARON Dacima Software Inc. Doorn Corporation Evado Clinical FIGmd Inc. Global Vision Technologies, Inc...
Read more